Reaction
Anthropic acquires Mithril Medicine and expands Claude-powered drug discovery partnerships
Anthropic acquired Mithril Medicine, a biotech founded by Cody Tranbarger that used Claude to coordinate lab work. Mithril achieved promising mouse results for rare muscular dystrophy treatment in under 18 months.
TLDR
The acquisition and partnerships demonstrate Claude operating in real scientific and operational workflows at scale. The one-person company model enabled by AI resonates amid AI-biotech crossover excitement. Mithril's efficiency in preclinical development—achieving results in under 18 months with external lab coordination—illustrates practical AI augmentation of drug discovery. Human trials could begin as early as late 2028 if results hold.
Combined views
17.7K
2 Sources, first seen ago
